Showing items 746-770 of 2549 (102 Page(s) Totally)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-03-04T07:51:22Z |
Description of soft tissue artifacts and related consequences on hindlimb kinematics during canine gait
|
Lin, C.-C.;Wang, S.-N.;Lu, M.;Chao, T.-Y.;Lu, T.-W.;Wu, C.-H.; Lin, C.-C.; Wang, S.-N.; Lu, M.; Chao, T.-Y.; Lu, T.-W.; Wu, C.-H.; CHING-HO WU |
| 臺大學術典藏 |
2021-03-04T07:51:20Z |
Evaluation of a multibody kinematics optimization method for three-dimensional canine pelvic limb gait analysis
|
Lin, C.-C.;Wu, C.-H.;Chou, P.-Y.;Wang, S.-N.;Hsu, W.-R.;Lu, T.-W.; Lin, C.-C.; Wu, C.-H.; Chou, P.-Y.; Wang, S.-N.; Hsu, W.-R.; Lu, T.-W.; CHING-HO WU |
| 臺大學術典藏 |
2021-03-04T02:36:03Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C.;Yeh K.-H.;Yang C.-H.;Hsu C.;Yu-Chieh Tsai;Hsu W.-L.;Cheng A.-L.;Hsu C.-H.; Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; YU-CHIEH TSAI; Hsu W.-L.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; YU-CHIEH TSAI; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu F.-M.; Lin C.-C.; Lee J.-M.; Chang Y.-L.; Hsu C.-H.; YU-CHIEH TSAI; Lee Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Hsu F.-M.; Lee Y.-C.; Lee J.-M.; Hsu C.-H.; Lin C.-C.; YU-CHIEH TSAI; Wu J.-K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:36:00Z |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma
|
Hsu F.-M.;Lee J.-M.;Huang P.-M.;Lin C.-C.;Hsu C.-H.;Yu-Chieh Tsai;Lee Y.-C.;Chia-Hsien Cheng J.; Hsu F.-M.; Lee J.-M.; Huang P.-M.; Lin C.-C.; Hsu C.-H.; YU-CHIEH TSAI; Lee Y.-C.; Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-03T07:39:49Z |
The Advanced Thin Film Micro LED Array
|
Lin, C.-C.; Yang, S.-M.; Kuo, W.-H.; Liang, K.-L.; Fang, Y.-H.; Wu, C.-I.; CHIH-I WU |
| 臺大學術典藏 |
2021-03-03T03:01:14Z |
Myomectomy through the uterine cervix using forceps under sonographic guidance
|
Lin C.-C.; Ou M.-C.; Hsiao S.-M.; HO-HSIUNG LIN |
| 臺大學術典藏 |
2021-03-02T08:39:45Z |
Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate
|
Wen W.-H.; Chen H.-L.; Shih T.T.-F.; Wu J.-F.; Ni Y.-H.; Lee C.-N.; Zhao L.-L.; Lai M.-W.; Mu S.-C.; Tung Y.-C.; Hsu H.-Y.; Chang M.-H.; Shyu M.K.; Hwa H.L.; Su Y.N.; Shih J.C.; KUANG-HAN CHAO; Chiu Y.C.; Chang K.C.; Liu C.J.; Su T.H.; Chen D.S.; Chen S.M.; Lin C.C.; Lin P.Y.; Yang W.R.; Hu J.J.; Yang C.K.; Chang Y.K.; Chen K.H.; Lin H.H.; Lin Y.H.; Chen H.J.; Pan H.S.; Lau B.H.; Lee C.L.; Cheng P.J.; Chang Y.L.; Chiueh H.Y.; Wang T.H.; Hsu J.J.; Lo L.M.; Hsieh C.L.; Cheng S.W.; Tsai M.S.; Lin L.H.; She B.Q.; Peng F.S.; Lin Y.C.; Chen C.P.; Huang J.P.; Yeung C.Y.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) |
| 臺大學術典藏 |
2021-03-02T06:21:25Z |
Hepatitis B virus marker in Chinese twins
|
Lin T.M.;Chen C.J.;Wu M.M.;Yang C.S.;Chen J.S.;Lin C.C.;Kwang T.Y.;Hsu S.T.;Shin-Yu Lin;Hsu L.C.; Lin T.M.; Chen C.J.; Wu M.M.; Yang C.S.; Chen J.S.; Lin C.C.; Kwang T.Y.; Hsu S.T.; SHIN-YU LIN; Hsu L.C. |
| 臺大學術典藏 |
2021-03-02T06:12:17Z |
Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate
|
Wen W.-H.; Chen H.-L.; Shih T.T.-F.; Wu J.-F.; Ni Y.-H.; Lee C.-N.; Zhao L.-L.; Lai M.-W.; Mu S.-C.; Tung Y.-C.; Hsu H.-Y.; Chang M.-H.; MING-KWANG SHYU; Hwa H.L.; Su Y.N.; Shih J.C.; Chao K.H.; Chiu Y.C.; Chang K.C.; Liu C.J.; Su T.H.; Chen D.S.; Chen S.M.; Lin C.C.; Lin P.Y.; Yang W.R.; Hu J.J.; Yang C.K.; Chang Y.K.; Chen K.H.; Lin H.H.; Lin Y.H.; Chen H.J.; Pan H.S.; Lau B.H.; Lee C.L.; Cheng P.J.; Chang Y.L.; Chiueh H.Y.; Wang T.H.; Hsu J.J.; Lo L.M.; Hsieh C.L.; Cheng S.W.; Tsai M.S.; Lin L.H.; She B.Q.; Peng F.S.; Lin Y.C.; Chen C.P.; Huang J.P.; Yeung C.Y.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) |
| 臺大學術典藏 |
2021-02-23T08:26:37Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C.; SUNG-HSIN KUO; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-02-23T08:26:20Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; SUNG-HSIN KUO; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; Liu J.-H.; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2021-02-23T08:26:15Z |
A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma
|
Yang S.-H.;Shao Y.-Y.;Lin C.-C.;Sung-Hsin Kuo;Cheng A.-L.;Yeh K.-H.; Yang S.-H.; Shao Y.-Y.; Lin C.-C.; SUNG-HSIN KUO; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-02-18T01:45:20Z |
Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open-Label, Phase Ib Study
|
Lin C.-C.;Yang T.-S.;Yen C.-J.;Cheng R.;Liu J.;Chiun Hsu; Lin C.-C.; Yang T.-S.; Yen C.-J.; Cheng R.; Liu J.; Chiun Hsu |
| 臺大學術典藏 |
2021-02-17T03:49:11Z |
The Validity of Inventory of Depressive Symptomatology, with Professional Help-seeking among Individuals with Social Anxiety Disorder
|
Chen J.-T.;Lin Y.-T.;Tseng H.-H.;Lin A.-S.;Hsi-Chung Chen;Bai Y.-M.;Lin C.-C.; Chen J.-T.; Lin Y.-T.; Tseng H.-H.; Lin A.-S.; HSI-CHUNG CHEN; Bai Y.-M.; Lin C.-C. |
| 臺大學術典藏 |
2021-02-08T07:23:50Z |
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus
|
Chen H.-L.;Lee C.-N.;Chang C.-H.;Ni Y.-H.;Shyu M.-K.;Chen S.-M.;Hu J.-J.;Lin H.H.;Zhao L.-L.;Mu S.-C.;Lai M.-W.;Lee C.-L.;Lin H.-M.;Tsai M.-S.;Hsu J.-J.;Chen D.-S.;Kin-Wei Chan;Chang M.-H.;Su Y.-N.;Shih J.-C.;Chao K.-H.;Wu J.-F.;Hsu H.-Y.;Liu C.-J.;Su T.-H.;Lin C.-C.;Lin P.-Y.;Yang W.-R.;Yang C.-K.;Chang Y.-K.;Chen K.-H.;Lin Y.-H.;Chen H.-J.;Pan H.-S.;Lau B.-H.;Cheng P.-J.;Chang Y.-L.;Chiueh H.-Y.;Wang T.-H.;Lo L.-M.;Hsieh C.-L.;Cheng S.-W.;Lin L.-H.;She B.-Q.;Koh K.-J.;Hung Y.-L.;Peng F.-S.;Lin Y.-C.;Wu T.-C.;Chen C.-Y.;Chen C.-P.;Huang J.-P.;Yeung C.-Y.;Lin C.-J.;Chiu W.-T.;Wang D.-S.;Lin W.-T.;Hwang K.-S.;Huang C.-F.;Taiwan Study Group For The Prevention Of Mother-To-Infant Transmission Of Hbv (Premit Study); Chen H.-L.; Lee C.-N.; Chang C.-H.; Ni Y.-H.; Shyu M.-K.; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; Chen D.-S.; KIN-WEI CHAN; Chang M.-H.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Wu J.-F.; Hsu H.-Y.; Liu C.-J.; Su T.-H.; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study) |
| 臺大學術典藏 |
2021-02-05T06:29:34Z |
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
|
Yang Y.-T.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; WEN-CHIEN CHOU; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Kuo Y.-Y.; Huang S.-Y.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:34Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Hou H.-A.; Lin C.-C.; WEN-CHIEN CHOU; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:33Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Lin C.-C.;Hou H.-A.;Wen-Chien Chou;Kuo Y.-Y.;Wu S.-J.;Liu C.-Y.;Chen C.-Y.;Tseng M.-H.;Huang C.-F.;Lee F.-Y.;Liu M.-C.;Liu C.-W.;Tang J.-L.;Yao M.;Huang S.-Y.;Hsu S.-C.;Ko B.-S.;Tsay W.;Chen Y.-C.;Tien H.-F.; Lin C.-C.; Hou H.-A.; WEN-CHIEN CHOU; Kuo Y.-Y.; Wu S.-J.; Liu C.-Y.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:31Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Hou H.-A.;Kuo Y.-Y.;Tang J.-L.;Wen-Chien Chou;Yao M.;Lai Y.-J.;Lin C.-C.;Chen C.-Y.;Liu C.-Y.;Tseng M.-H.;Huang C.-F.;Chiang Y.-C.;Lee F.-Y.;Liu M.-C.;Liu C.-W.;Huang S.-Y.;Ko B.-S.;Wu S.-J.;Tsay W.;Chen Y.-C.;Tien H.-F.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; WEN-CHIEN CHOU; Yao M.; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
Showing items 746-770 of 2549 (102 Page(s) Totally)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
View [10|25|50] records per page
